1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA).
This solicitation invites eligible United States small business concerns to submit SBIR applications for research and development that has a strong potential for commercialization and aligns with the missions of NIH, CDC, and FDA to improve health and save lives. The program supports the development of promising technologies and products in the life sciences.
Get alerted about grants like this
Save a search for “National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Eligible United States small business concerns (SBCs) that are US-owned and operated. Small businesses must have no more than 500 employees, majority ownership by U.S. Citizens or another U.S.-based small business, and all work performed in the U.S. Confirm the full requirements in the official notice before applying.
The current listing shows generally up to $600K for Phase I and $3.5M for Phase II awards. Specific grant amounts vary. Verify award ceilings, matching requirements, and allowable costs in the official notice.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
HRSA's brand-new Rural Hospital Provider Assistance Program splits $24.75M among eligible rural hospitals with 50 or fewer beds and a Medicare wage index under 0.90. It's not scored competitively — every eligible hospital that applies by July 27 gets a roughly equal share. Here's how the three eligibility numbers work and why registration, not narrative, is the real risk.
Read articleHUD announced the FY25 Rural Capacity Building NOFO on May 18, 2026 with a July 6 deadline. Section 4 has three statutory intermediaries — Enterprise, LISC, and Habitat. RCB is a different door, and most rural housing nonprofits are misreading which one they qualify for.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read article